TITLE

Omalizumab

PUB. DATE
November 2017
SOURCE
Reactions Weekly;11/18/2017, Vol. 1678 Issue 1, p138
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
126306650

 

Related Articles

  • Don't delay corticosteroid inhalation therapy for asthmatics.  // Modern Medicine;Nov96, Vol. 64 Issue 11, p56 

    Presents an abstract of the study `Is Delayed Introduction of Inhaled Corticosteroids Harmful in Patients With Obstructive Airways Disease (asthma and COPD)?,' by S.E. Overbeek, H.A.M. Kerstjens, J.M. Bogaard et al and published in the July 1996 issue of the periodical `Chest.'

  • Outcomes for Laparoscopic Bilateral Adrenalectomy. Hasan, R.; Harold, K.L.; Matthews, B.D.; Kercher, K.W.; Sing, R.F.; Heniford, B.T. // Journal of Laparoendoscopic & Advanced Surgical Techniques;Aug2002, Vol. 12 Issue 4, p233 

    Background and Purpose: Laparoscopic adrenalectomy has become the preferred surgical approach to manage adrenal disorders. Bilateral adrenalectomy is performed for diseases that are unresponsive to medical management and, frequently, for neoplastic disease. The aim of this study was to review...

  • Systemic Corticosteroid Therapy: Pharmacology and Endocrinologic Considerations. Melby, James C. // Annals of Internal Medicine;Oct74, Vol. 81 Issue 4, p505 

    Examines the clinical pharmacology of systemic corticosteroid administration and concepts of systemic corticositeroid therapy. Actions of the corticosteroids; Biochemical and metabolic effects; Significance of the structural alterations of cortisol; Modalities of corticosteroid therapy.

  • Long-term corticosteroids in patients with COPD. Simonelli, Paul F. // Cortlandt Forum;11/25/97, Vol. 10 Issue 11, p40 

    Reports on the effects of long-term corticosteroids in patients with chronic obstructive pulmonary disease (COPD) on clinical symptoms and lung-function decline. Treatment effect on frequency and duration of exacerbations; Effectiveness of treating COPD with a combination of inhaled plus oral...

  • IDIOPATHIC LYMPHEDEMA TREATMENT WITH ADRENAL STEROIDS. Vainder, Milton // Angiology;Oct1963, Vol. 14 Issue 10, p524 

    It has been shown that edema fluid provides an excellent media for the proliferation of fibroblasts. In patients in whom edema has been long standing (irrespective of the etiology�but provided it was on a local basis) the results of previous forms of therapy have been legs rewarding than in...

  • Suppression of Adrenal Function by Low-dose Prednisone: Assessment with 24-hour Urinary Steroid Hormone Profiles -- A Review of Five Cases. Friel, Patrick N.; Alexander, Thomas; Wright, Jonathan V. // Alternative Medicine Review;Mar2006, Vol. 11 Issue 1, p40 

    The impact of the synthetic glucocorticoid prednisone on adrenal steroid hormone production was examined using 24-hour urinary steroid hormone profiling. Five women, who were chronically taking low-dose prednisone, were tested, and the relevant literature was reviewed. As expected, adrenal...

  • Association between azathioprine therapy and lymphoma in rheumatoid disease. Pitt, P. I.; Sultan, A. H.; Malone, M.; Andrews, V.; Hamilton, E. B. D. // Journal of the Royal Society of Medicine;Jul1987, Vol. 80 Issue 7, p428 

    Three out of 41 patients treated with azathioprine and low-dose corticosteroids from 1976 to 1983 developed non-Hodgkin's lymphoma. This strikingly high incidence of lymphoma may be a reflection of long-term use of azathioprine.

  • Multifocal avascular necrosis after liver transplantation: an unusual presentation of the antiphospholipid syndrome. Mundo, J.; Peris, P.; Monegal, A.; Navasa, M.; Cervera, R.; Guañabens, N. // Lupus;2006, Vol. 15 Issue 5, p304 

    We describe the case of a 31-year old man who presented with an antiphospholipid syndrome (APS), which manifested as multifocal avascular necrosis (AVN) one year after orthotopic liver transplantation. The patient developed multiple AVN affecting hips, left knee, humerus and tarsal bones just...

  • Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus. Bhattoa, Harjit; Kiss, Emese; Bettembuk, Peter; Balogh, Adam // Rheumatology International;Nov2001, Vol. 21 Issue 3, p97 

    The aim of this study was to evaluate bone mineral density (BMD), biochemical markers of bone turnover, and hormone levels in men with systemic lupus erythematosus (SLE). BMD at L2–L4 lumbar vertebrae (LS), left proximal femur neck, and radius at the ultradistal and mid-33% region was...

  • GP REGISTRAR: Osteoporosis - part two. Newson, Louise // GP: General Practitioner;2/16/2004, p53 

    Most patients taking an oral corticosteroid long term experience a fall in bone mass and bone mineral density. Longitudinal studies have shown that the most rapid rate of bone loss occurs in the first year of treatment and continues at a rate of two to three times normal on long-term therapy in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics